Results 41 to 50 of about 3,153,921 (233)

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

open access: yesGut, 2021
Objective Although COVID-19 is primarily a respiratory illness, there is mounting evidence suggesting that the GI tract is involved in this disease. We investigated whether the gut microbiome is linked to disease severity in patients with COVID-19, and ...
Yun Kit Yeoh   +23 more
semanticscholar   +1 more source

Evaluation of Olfactory Function by Iranian Smell Diagnostic Test in Patients with Parkinson's disease in North of Iran [PDF]

open access: yesIranian Journal of Otorhinolaryngology, 2021
Introduction: Parkinson's disease is a neurodegenerative and multisystem disorder affecting systems more than the motor system. The olfactory disorder is an early non-motor symptom of Parkinson's disease.
Keyvan Kiakojuri   +4 more
doaj   +1 more source

Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease

open access: yesJournal of Immunology, 2019
Influenza viruses continue to be a major global health threat. Severity and clinical outcome of influenza disease is determined by both viral and host factors.
A. Gounder, A. Boon
semanticscholar   +1 more source

Modifications of Gait as Predictors of Natural Osteoarthritis Progression in STR/Ort Mice [PDF]

open access: yes, 2014
Objective. Osteoarthritis (OA) is a common chronic disease for which disease-modifying therapies are not currently available. Studies to seek new targets for slowing the progress of OA rely on mouse models, but these do not allow for longitudinal ...
Poulet, B   +10 more
core   +5 more sources

Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain.

open access: yesJAMA pediatrics, 2020
This case series describes the testing for and treatment of children with coronavirus disease 2019 (COVID-19) in Madrid, Spain.
A. Tagarro   +6 more
semanticscholar   +1 more source

Invasive Haemophilus influenzae Disease in Adults ≥65 Years, United States, 2011. [PDF]

open access: yes, 2014
BackgroundSince the introduction of the Haemophilus influenzae serotype b vaccine, H influenzae epidemiology has shifted. In the United States, the largest burden of disease is now in adults aged ≥65 years.
Bennett, Nancy   +15 more
core   +1 more source

Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience

open access: yesJournal of Autoimmunity, 2020
COVID-19 has become one of the worst infectious disease outbreaks of recent times, with over 2.1 million cases and 120,000 deaths so far. Our study investigated the demographic, clinical, laboratory and imaging features of 63 patients with COVID-19 in ...
Ying Sun   +6 more
semanticscholar   +1 more source

Progression of Moderate to Severe Carotid Disease [PDF]

open access: yesJournal of Vascular Surgery, 2015
Our goals were to investigate the degree to which patient demographics, risk factors, laboratory data, and medications influence moderate carotid disease progression among patients with asymptomatic moderate carotid disease and whether such associations are solely based on how progression is defined. In addition, we aimed to establish optimal threshold
William K, Winter   +4 more
openaire   +3 more sources

Sensorimotor processing for balance in spinocerebellar ataxia type 6. [PDF]

open access: yes, 2015
We investigated whether balance impairments caused by cerebellar disease are associated with specific sensorimotor processing deficits that generalize across all sensory modalities.
Bunn, LM   +4 more
core   +1 more source

FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination. [PDF]

open access: yes, 2014
BackgroundFTY720 (fingolimod) is the first oral drug approved by the Food and Drug Administration for treatment of patients with the relapsing-remitting form of the human demyelinating disease multiple sclerosis.
Blanc, Caroline A   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy